Paul T Yun, MD
Otolaryngology · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yun’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A71139 · Current
Licensed to practise in California · since 2000 · expires 2027-08-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Waverley Surgery Center, LPAmbulatory Surgery Center · Palo Alto, CA1.47% owner since 2015 · accredited by AAAHCAccreditation Renewed4 inspections, 3 with deficiencies · last 2024-04-25
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$122,386
Medicare paid this office $122,386 for 777 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 218 | $23,576 | $79 |
| Short return visit | 267 | $21,026 | $49 |
| New patient visit (30+ min) | 175 | $16,508 | $94 |
| Return visit (30+ min) | 86 | $11,539 | $110 |
| Incision of fluid canal of inner ear with infusion of drugs | 13 | $9,244 | $220 |
See all 16 services
| Short return visit (20+ min) | 218 | $23,576 | $79 |
| Short return visit | 267 | $21,026 | $49 |
| New patient visit (30+ min) | 175 | $16,508 | $94 |
| Return visit (30+ min) | 86 | $11,539 | $110 |
| Incision of fluid canal of inner ear with infusion of drugs | 13 | $9,244 | $220 |
| New patient visit (45+ min) | 54 | $7,592 | $141 |
| New patient visit (15+ min) | 116 | $6,941 | $60 |
| Incision, aspiration, and/or inflation of eardrum | 21 | $4,735 | $189 |
| Simple control of nose bleed | 21 | $4,362 | $156 |
| Diagnostic exam of voice box using a flexible endoscope | 32 | $4,162 | $126 |
| Diagnostic exam of voice box using an endoscope with mirror | 40 | $3,460 | $84 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $2,468 | $190 |
| Exam of ear using a microscope | 15 | $456 | $30 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $436 | $40 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $207 | $15 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $14 | None |
Who their Medicare patients are
777 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 21% · Women 58% · Also on Medicaid 5% · Health risk score 1.05. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 63% · Coronary heart disease 28% · Cancer 19% · Atrial fibrillation 18% · Heart failure 15% · Diabetes 14% · Chronic kidney disease 14% · Depression 13% · COPD 9% · Dementia 5% · Stroke 5%.
The office billed $630,458, Medicare allowed $167,907 and paid $122,386; for 1,679 services of 38 kinds; $502 of it was for drugs given in the office and $121,885 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 777 | 1,679 | 77 | 1.05 | $630,458 | $122,386 |
| 2023 | 845 | 1,692 | 77 | 1.02 | $661,005 | $135,375 |
| 2022 | 781 | 1,511 | 77 | 1.03 | $590,356 | $110,036 |
| 2021 | 721 | 1,314 | 77 | 1.06 | $462,213 | $94,778 |
| 2020 | 588 | 1,120 | 76 | 1.07 | $439,716 | $75,809 |
| 2019 | 726 | 1,372 | 77 | 1.16 | $560,191 | $97,633 |
| 2018 | 712 | 1,257 | 76 | 1.04 | $494,254 | $96,309 |
| 2017 | 688 | 1,196 | 76 | 1.06 | $420,630 | $88,866 |
| 2016 | 657 | 1,140 | 77 | 1.09 | $357,935 | $83,461 |
| 2015 | 636 | 1,124 | 77 | 1.00 | $335,634 | $83,909 |
| 2014 | 551 | 1,016 | 77 | 0.99 | $297,831 | $77,367 |
| 2013 | 505 | 917 | 76 | 0.99 | $239,514 | $70,957 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 232 | $23,341 | $79 |
| Short return visit | 272 | $18,496 | $50 |
| New patient visit (30+ min) | 178 | $16,120 | $91 |
| New patient visit (45+ min) | 75 | $10,629 | $142 |
| Return visit (30+ min) | 83 | $10,615 | $107 |
| New patient visit (15+ min) | 137 | $8,560 | $62 |
| Incision, aspiration, and/or inflation of eardrum | 30 | $6,676 | $196 |
| Diagnostic exam of voice box using a flexible endoscope | 46 | $5,820 | $121 |
| Diagnostic exam of voice box using an endoscope with mirror | 53 | $4,900 | $87 |
| Simple control of nose bleed | 20 | $4,814 | $155 |
| Removal of impacted ear wax | 87 | $2,737 | $27 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $2,149 | $195 |
| Influenza vaccine split virus, preservative free | 13 | $935 | $72 |
| Administration of influenza virus vaccine | 13 | $472 | $36 |
2022: 12 services
| Short return visit (20+ min) | 219 | $20,361 | $76 |
| Removal of impacted ear wax | 251 | $13,588 | $36 |
| New patient visit (30+ min) | 143 | $12,762 | $89 |
| New patient visit (45+ min) | 70 | $10,164 | $145 |
| Return visit (30+ min) | 72 | $9,440 | $110 |
| Short return visit | 125 | $7,016 | $47 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | $6,095 | $124 |
| New patient visit (15+ min) | 101 | $5,966 | $59 |
| Incision, aspiration, and/or inflation of eardrum | 16 | $4,789 | $200 |
| Simple control of nose bleed | 23 | $4,274 | $158 |
| Diagnostic exam of voice box using an endoscope with mirror | 31 | $2,765 | $89 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $2,548 | $150 |
2021: 12 services
| Removal of impacted ear wax | 282 | $14,844 | $38 |
| Short return visit (20+ min) | 131 | $13,584 | $79 |
| New patient visit (30+ min) | 121 | $11,723 | $97 |
| Return visit (30+ min) | 74 | $9,588 | $113 |
| New patient visit (45+ min) | 51 | $7,565 | $148 |
| Short return visit | 111 | $6,553 | $52 |
| New patient visit (15+ min) | 80 | $4,642 | $58 |
| Simple control of nose bleed | 23 | $4,585 | $139 |
| Tying or biopsy of artery on side of skull | 12 | $3,156 | $263 |
| Diagnostic exam of voice box using a flexible endoscope | 24 | $2,898 | $116 |
| Incision, aspiration, and/or inflation of eardrum | 11 | $2,711 | $181 |
| Diagnostic exam of voice box using an endoscope with mirror | 25 | $2,547 | $91 |
2020: 10 services
| New patient visit (30+ min) | 137 | $11,454 | $84 |
| Removal of impacted ear wax | 220 | $11,431 | $38 |
| Short return visit (20+ min) | 118 | $9,986 | $67 |
| Return visit (30+ min) | 88 | $9,411 | $96 |
| Short return visit | 64 | $5,270 | $44 |
| Simple control of nose bleed | 23 | $4,366 | $136 |
| Tying or biopsy of artery on side of skull | 12 | $3,505 | $292 |
| New patient visit (15+ min) | 56 | $3,331 | $59 |
| Diagnostic exam of voice box using a flexible endoscope | 17 | $1,781 | $105 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $593 | $40 |
2019: 11 services
| New patient visit (30+ min) | 200 | $18,288 | $91 |
| Removal of impacted ear wax | 245 | $13,356 | $38 |
| Return visit (30+ min) | 117 | $12,859 | $98 |
| Short return visit (20+ min) | 145 | $12,253 | $66 |
| Diagnostic exam of voice box using a flexible endoscope | 50 | $5,845 | $106 |
| New patient visit (15+ min) | 80 | $5,381 | $67 |
| Simple control of nose bleed | 27 | $4,119 | $121 |
| Short return visit | 82 | $3,840 | $39 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $3,193 | $188 |
| Incision, aspiration, and/or inflation of eardrum | 14 | $2,775 | $173 |
| Test to assess middle ear function | 13 | $191 | $14 |
2018: 10 services
| New patient visit (30+ min) | 225 | $20,754 | $92 |
| Short return visit (20+ min) | 146 | $13,093 | $64 |
| Removal of impacted ear wax | 250 | $12,664 | $37 |
| Return visit (30+ min) | 95 | $9,770 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 18 | $5,065 | $211 |
| Short return visit | 86 | $4,500 | $41 |
| Diagnostic exam of voice box using a flexible endoscope | 36 | $4,161 | $107 |
| Incision, aspiration, and/or inflation of eardrum | 16 | $4,058 | $193 |
| New patient visit (15+ min) | 56 | $3,868 | $69 |
| Simple control of nose bleed | 24 | $3,854 | $117 |
2017: 12 services
| New patient visit (30+ min) | 177 | $14,645 | $83 |
| Short return visit (20+ min) | 152 | $12,759 | $61 |
| Removal of impacted ear wax | 230 | $11,827 | $39 |
| Return visit (30+ min) | 92 | $8,734 | $88 |
| Incision, aspiration, and/or inflation of eardrum | 21 | $5,597 | $200 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $5,378 | $207 |
| New patient visit (15+ min) | 81 | $5,197 | $64 |
| Short return visit | 100 | $4,065 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 33 | $3,710 | $100 |
| Tying or biopsy of artery on side of skull | 12 | $3,391 | $283 |
| Simple control of nose bleed | 26 | $2,705 | $85 |
| Test to assess middle ear function | 13 | $165 | $13 |
2016: 11 services
| New patient visit (30+ min) | 179 | $16,446 | $92 |
| Removal of impacted ear wax | 258 | $13,857 | $40 |
| Short return visit (20+ min) | 139 | $11,049 | $63 |
| Return visit (30+ min) | 72 | $7,327 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 48 | $4,966 | $103 |
| New patient visit (15+ min) | 65 | $4,123 | $63 |
| Incision, aspiration, and/or inflation of eardrum | 14 | $3,707 | $218 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $3,358 | $210 |
| Short return visit | 64 | $3,076 | $38 |
| Simple control of nose bleed | 21 | $2,834 | $86 |
| Test to assess middle ear function | 14 | $180 | $13 |
2015: 10 services
| New patient visit (30+ min) | 170 | $15,887 | $93 |
| Short return visit (20+ min) | 166 | $13,675 | $61 |
| Removal of impacted ear wax | 230 | $11,623 | $40 |
| Return visit (30+ min) | 75 | $7,671 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $4,628 | $96 |
| New patient visit (15+ min) | 70 | $4,592 | $66 |
| Incision, aspiration, and/or inflation of eardrum | 18 | $4,106 | $187 |
| Short return visit | 68 | $3,153 | $39 |
| Simple control of nose bleed | 25 | $2,839 | $86 |
| Test to assess middle ear function | 14 | $181 | $13 |
2014: 11 services
| Short return visit (20+ min) | 169 | $14,046 | $62 |
| New patient visit (30+ min) | 129 | $11,688 | $91 |
| Removal of impacted ear wax | 207 | $10,429 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 20 | $7,278 | $214 |
| New patient visit (15+ min) | 65 | $4,096 | $63 |
| Return visit (30+ min) | 39 | $3,924 | $96 |
| Diagnostic exam of voice box using a flexible endoscope | 34 | $3,664 | $105 |
| Short return visit | 70 | $3,217 | $38 |
| Simple control of nose bleed | 25 | $2,890 | $78 |
| Incision, aspiration, and/or inflation of eardrum | 11 | $2,417 | $201 |
| Test to assess middle ear function | 15 | $221 | $14 |
2013: 9 services
| Short return visit (20+ min) | 141 | $12,330 | $65 |
| New patient visit (30+ min) | 117 | $11,251 | $96 |
| Removal of impacted ear wax | 187 | $10,336 | $44 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $4,903 | $107 |
| Return visit (30+ min) | 38 | $3,913 | $98 |
| New patient visit (15+ min) | 58 | $3,755 | $65 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $3,667 | $216 |
| Short return visit | 61 | $2,962 | $42 |
| Simple control of nose bleed | 19 | $2,275 | $84 |
Drugs they prescribed that Part D paid
$10,208
Pharmacies billed $10,208 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
323 generic and 18 brand-name prescriptions · $10,208 in drug cost · 58 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 24 | $2,596 | $108 |
| Ipratropium | 56 | $2,029 | $36 |
| Azelastine | 38 | $1,230 | $32 |
| Omeprazole | 18 | $362 | $20 |
| Pantoprazole | 16 | $314 | $20 |
See all 10 drugs
| Ciprofloxacin-Dexamethasone | 24 | $2,596 | $108 |
| Ipratropium | 56 | $2,029 | $36 |
| Azelastine | 38 | $1,230 | $32 |
| Omeprazole | 18 | $362 | $20 |
| Pantoprazole | 16 | $314 | $20 |
| Amoxicillin-Clavulanate Potass | 24 | $220 | $9 |
| Mometasone Furoate | 27 | $217 | $8 |
| Mupirocin | 20 | $174 | $9 |
| Methylprednisolone | 13 | $123 | $9 |
| Prednisone | 16 | $98 | $6 |
Year by year
| 2024 | 341 | 172 | None | 5% | $10,208 |
| 2023 | 350 | 179 | None | 5% | $14,150 |
| 2022 | 390 | 185 | None | 7% | $19,881 |
| 2021 | 335 | 155 | None | 10% | $18,322 |
| 2020 | 255 | 133 | None | 6% | $14,840 |
| 2019 | 250 | 138 | None | 7% | $11,495 |
| 2018 | 279 | 157 | 4% (11) | 8% | $13,411 |
| 2017 | 215 | 117 | None | 10% | $11,936 |
| 2016 | 197 | 96 | None | 15% | $10,959 |
| 2015 | 274 | 125 | None | 20% | $12,852 |
| 2014 | 284 | 113 | None | 23% | $14,579 |
| 2013 | 222 | 84 | None | 25% | $12,510 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Ciprofloxacin-Dexamethasone | 18 | $2,689 | $149 |
| Ipratropium | 62 | $1,551 | $25 |
| Azelastine | 30 | $1,357 | $45 |
| Mometasone Furoate | 27 | $983 | $36 |
| Fluocinolone Acetonide Oil | 13 | $865 | $67 |
| Amoxicillin-Clavulanate Potass | 24 | $328 | $14 |
| Omeprazole | 11 | $218 | $20 |
| Mupirocin | 22 | $208 | $9 |
| Prednisone | 21 | $173 | $8 |
| Methylprednisolone | 14 | $131 | $9 |
2022: 12 drugs
| Ciprofloxacin-Dexamethasone | 26 | $3,971 | $153 |
| Ipratropium | 61 | $2,113 | $35 |
| Azelastine | 35 | $1,875 | $54 |
| Mometasone Furoate | 26 | $1,285 | $49 |
| Fluocinolone Acetonide Oil | 13 | $896 | $69 |
| Flunisolide | 15 | $761 | $51 |
| Fluticasone Propionate | 11 | $536 | $49 |
| Omeprazole | 20 | $366 | $18 |
| Amoxicillin-Clavulanate Potass | 22 | $322 | $15 |
| Mupirocin | 18 | $173 | $10 |
| Methylprednisolone | 13 | $109 | $8 |
| Sulfamethoxazole-Trimethoprim | 13 | $88 | $7 |
2021: 9 drugs
| Ciprofloxacin-Dexamethasone | 22 | $3,589 | $163 |
| Ipratropium | 35 | $2,031 | $58 |
| Mometasone Furoate | 39 | $1,385 | $36 |
| Azelastine | 32 | $1,213 | $38 |
| Neomycin-Polymyxin-Hc | 11 | $704 | $64 |
| Fluticasone Propionate | 16 | $618 | $39 |
| Amoxicillin-Clavulanate Potass | 18 | $238 | $13 |
| Omeprazole | 21 | $173 | $8 |
| Methylprednisolone | 13 | $98 | $8 |
2020: 5 drugs
| Ipratropium | 38 | $3,368 | $89 |
| Mometasone Furoate | 30 | $1,414 | $47 |
| Fluticasone Propionate | 21 | $915 | $44 |
| Azelastine | 20 | $895 | $45 |
| Amoxicillin-Clavulanate Potass | 15 | $170 | $11 |
2019: 7 drugs
| Ipratropium | 37 | $1,552 | $42 |
| Fluticasone Propionate | 19 | $686 | $36 |
| Neomycin-Polymyxin-Hc | 11 | $639 | $58 |
| Mometasone Furoate | 35 | $620 | $18 |
| Amoxicillin-Clavulanate Potass | 18 | $254 | $14 |
| Omeprazole | 12 | $119 | $10 |
| Prednisone | 12 | $88 | $7 |
2018: 8 drugs
| Ciprodex | 14 | $3,152 | $225 |
| Ipratropium | 28 | $1,515 | $54 |
| Neomycin-Polymyxin-Hc | 20 | $1,056 | $53 |
| Mometasone Furoate | 26 | $606 | $23 |
| Fluticasone Propionate | 21 | $462 | $22 |
| Amoxicillin-Clavulanate Potass | 23 | $287 | $12 |
| Omeprazole | 14 | $206 | $15 |
| Methylprednisolone | 12 | $132 | $11 |
2017: 6 drugs
| Ipratropium | 18 | $1,032 | $57 |
| Clarithromycin Er | 11 | $938 | $85 |
| Mometasone Furoate | 18 | $887 | $49 |
| Clarithromycin | 11 | $653 | $59 |
| Fluticasone Propionate | 19 | $315 | $17 |
| Amoxicillin-Clavulanate Potass | 26 | $288 | $11 |
2016: 6 drugs
| Veramyst | 12 | $2,302 | $192 |
| Mometasone Furoate | 19 | $2,108 | $111 |
| Ipratropium | 27 | $676 | $25 |
| Acetazolamide | 12 | $412 | $34 |
| Fluticasone Propionate | 21 | $282 | $13 |
| Amoxicillin-Clavulanate Potass | 14 | $178 | $13 |
2015: 9 drugs
| Qnasl | 20 | $2,961 | $148 |
| Veramyst | 11 | $1,752 | $159 |
| Fluticasone Propionate | 50 | $703 | $14 |
| Acetazolamide | 12 | $578 | $48 |
| Neomycin-Polymyxin-Hc | 21 | $488 | $23 |
| Amoxicillin-Clavulanate Potass | 18 | $190 | $11 |
| Mometasone Furoate | 14 | $149 | $11 |
| Pantoprazole | 14 | $146 | $10 |
| Amoxicillin | 11 | $44 | $4 |
2014: 5 drugs
| Ciprodex | 12 | $1,910 | $159 |
| Nasonex | 12 | $1,777 | $148 |
| Fluticasone Propionate | 79 | $1,425 | $18 |
| Ipratropium | 14 | $388 | $28 |
| Amox Tr-Potassium Clavulanate | 19 | $359 | $19 |
2013: 4 drugs
| Fluticasone Propionate | 75 | $2,084 | $28 |
| Ciprodex | 14 | $2,074 | $148 |
| Nasonex | 11 | $1,726 | $157 |
| Ipratropium | 11 | $339 | $31 |
Money from drug and device companies
$4,200 in 2023
| 2023 | 1 | 3 | $4,200 | $4,200 |
| 2022 | 3 | 16 | $8,978 | $9,001 |
| 2021 | 2 | 16 | $18,008 | $18,019 |
| 2020 | 1 | 10 | $7,088 | $7,088 |
| 2019 | 4 | 12 | $2,520 | $2,719 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Propel | $4,200 | 3 payments
|
See all 3 published payments
| Medtronic | Consulting · 2023-05-02 | Propel | $1,050 |
| Medtronic | Consulting · 2023-01-18 | Propel | $1,050 |
| Medtronic | Consulting · 2023-01-18 | None | $2,100 |
See earlier years (2022, 2021, 2020, 2019)
2022: $9,001
| Medtronic | Propel | $4,568 | 8 payments
|
| Intersect ENT | Propel | $4,410 | 7 payments
|
| Stryker | Xpress Ent Dilation System | $23 | 1 payment
|
2021: $18,019
| Intersect ENT | Vensure | $18,008 | 15 payments
|
| Stryker | Xpress Ent Dilation System | $12 | 1 payment
|
2020: $7,088
| Intersect ENT | Propel | $7,088 | 10 payments
|
2019: $2,719
| Intersect ENT | Sinuva | $2,618 | 9 payments
|
| Aerin Medical | Vivaer Rf Stylus | $48 | 1 payment
|
| Smith+Nephew | Coblation - Tonsil Wands | $31 | 1 payment
|
| OptiNose US | Xhance | $21 | 1 payment
|
Professional record
- NPI
- 1174583355
- Licence
- CA A71139California A71139: Current · expires 2027-08-31
- Trained
- University of California, Davis School of Medicine, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A711390
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 1300 Crane St, Menlo Park, CA, 94025
- NPI first listed
- 2006-03-23
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304 · 300 Pasteur Dr, Stanford, CA, 94305